Guangxi Wuzhou Zhongheng Group Co Ltd banner

Guangxi Wuzhou Zhongheng Group Co Ltd
SSE:600252

Watchlist Manager
Guangxi Wuzhou Zhongheng Group Co Ltd Logo
Guangxi Wuzhou Zhongheng Group Co Ltd
SSE:600252
Watchlist
Price: 2.5 CNY 0.4%
Market Cap: ¥8B

Guangxi Wuzhou Zhongheng Group Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Guangxi Wuzhou Zhongheng Group Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Guangxi Wuzhou Zhongheng Group Co Ltd
SSE:600252
EPS (Diluted)
¥0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
EPS (Diluted)
¥0
CAGR 3-Years
28%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
EPS (Diluted)
¥1
CAGR 3-Years
25%
CAGR 5-Years
3%
CAGR 10-Years
11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
EPS (Diluted)
¥2
CAGR 3-Years
20%
CAGR 5-Years
-8%
CAGR 10-Years
1%
Zhejiang Nhu Co Ltd
SZSE:002001
EPS (Diluted)
¥2
CAGR 3-Years
24%
CAGR 5-Years
6%
CAGR 10-Years
26%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
EPS (Diluted)
¥9
CAGR 3-Years
N/A
CAGR 5-Years
241%
CAGR 10-Years
N/A
No Stocks Found

Guangxi Wuzhou Zhongheng Group Co Ltd
Glance View

Market Cap
8B CNY
Industry
Pharmaceuticals

Guangxi Wuzhou Zhongheng Group Co Ltd is an intriguing player nestled in China's vibrant industrial landscape. The company, with its roots firmly planted in the southeastern province of Guangxi, has carved a niche for itself in the pharmaceutical and health products sector. Since its establishment, Zhongheng Group has methodically expanded its operations, establishing a robust portfolio that includes everything from the cultivation and processing of Chinese medicinal herbs to the development and manufacturing of pharmaceutical products. This vertical integration ensures quality control from start to finish and allows the company to create an array of products, catering to a diverse market that values traditional Chinese medicine as much as modern health solutions. Zhongheng Group's revenue model hinges on its ability to efficiently blend traditional expertise with modern pharmaceutical practices, capitalizing on the increasing demand for health and wellness products. Through its comprehensive supply chain, the company can produce a competitive range of cost-effective pharmaceuticals and health supplements, positioning itself for profitability in a growing market. Additionally, the company's strategic emphasis on research and development facilitates innovation, allowing for the introduction of new products that meet evolving consumer needs. By maintaining a dynamic array of offerings and leveraging its integrated operations, Guangxi Wuzhou Zhongheng Group Co Ltd continues to navigate the competitive landscape of the pharmaceutical industry, ensuring its place as a key player in China's economic tapestry.

Intrinsic Value
1.32 CNY
Overvaluation 47%
Intrinsic Value
Price ¥2.5

See Also

What is Guangxi Wuzhou Zhongheng Group Co Ltd's EPS (Diluted)?
EPS (Diluted)
-0.1 CNY

Based on the financial report for Dec 31, 2025, Guangxi Wuzhou Zhongheng Group Co Ltd's EPS (Diluted) amounts to -0.1 CNY.

What is Guangxi Wuzhou Zhongheng Group Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
0%

Over the last year, the EPS (Diluted) growth was 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett